Periscope Capital Inc. Monterey Bio Acquisition Corp Transaction History

Periscope Capital Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$10.65 - $11.0 $2 Million - $2.06 Million	-187,600 Reduced 42.87%	250,000 $2.73 Million
Q4 2022 Feb 13, 2023	SELL	$10.2 - $10.5 $5.05 Million - $5.2 Million	-495,000 Reduced 53.08%	437,600 $4.59 Million
Q3 2022 Nov 08, 2022	BUY	$0.05 - $10.11 $4,520 - $913,944	90,400 Added 10.73%	932,600 $9.42 Million
Q2 2022 Aug 15, 2022	BUY	$9.96 - $10.06 $1.32 Million - $1.33 Million	132,488 Added 18.67%	842,200 $8.44 Million
Q1 2022 May 16, 2022	BUY	$9.85 - $9.96 $3.95 Million - $3.99 Million	400,712 Added 129.68%	709,712 $7.07 Million
Q4 2021 Feb 14, 2022	BUY	$9.85 - $9.9 $3.04 Million - $3.06 Million	309,000 New	309,000 $3.05 Million

Ticker MTRY
Exchange NASDAQ
Sector Financial Services
Industry Shell Companies
Shares Outstandng 14,375,000
Description
Monterey Bio Acquisition Corporation does not have significant operations. It focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or related business combination with one or more businesses in the biotech industry. The company was formerly known as Chardan FinTech Acquisition Corp. and change...

Get notified when there are updates to the investment portfolio of Periscope Capital Inc., based on Form 13F filings with the SEC.

Stay updated on Periscope Capital Inc. with notifications on news.